Single nucleotide polymorphisms in genes coding for folate pathway enzymes are determinants for methotrexate efficacy in early rheumatoid arthritis

被引:0
|
作者
Wessels, JAM
de Vries-Bouwstra, JK
Heijmans, BT
Goekoop-Ruiterman, YPM
Allaart, CF
Kerstens, PJ
van Zeben, D
Breedveld, FC
Dijkmans, BAC
Huizinga, TWJ
Guchelaar, HJ
机构
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] STRO Trial Grp, Leiden, Netherlands
来源
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:S351 / S352
页数:2
相关论文
共 50 条
  • [21] Polymorphisms in the folate pathway contribute to methotrexate effects during a dose escalation in rheumatoid arthritis.
    Kremer, Joel
    Greenstein, Neal
    Dervieux, Thierry
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S833 - S834
  • [22] Genetic determinants of methotrexate treatment in rheumatoid arthritis patients: a study of polymorphisms in the adenosine pathway
    Grabar, Petra Bohanec
    Rojko, Sabina
    Logar, Dusan
    Dolzan, Vita
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (05) : 931 - U186
  • [23] DISCONTINUATION OF METHOTREXATE TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND RELATIOMSHIPS WITH CANDIDATE SINGLE NUCLEOTIDE POLYMORPHISMS
    Soukup, T.
    Dosedel, M.
    Pavek, P.
    Nekvindova, J.
    Kubena, A. A.
    Barvik, I.
    Vicek, J.
    Bradna, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1070 - 1070
  • [24] Polymorphisms in Genes Involved in Methotrexate Pathway: Predictor of Response to Methotrexate Therapy in Indian Rheumatoid Arthritis Patients
    Singh, Ankita
    Nair, Harikrishnan
    Gupta, Vikas
    Sekhar, Pradeepta
    Misra, Ramnath
    Aggarwal, Amita
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Genetic polymorphisms in the folate pathway are associated with methotrexate efficacy and adverse effects in Juvenile Idiopathic Arthritis
    Heijstek, Marloes W.
    Wulffraat, Nico M.
    Eken, Yusuf
    Pluijm, Saskia M. F.
    Rademaker, Karin M. A.
    de Jonge, Robert
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S499 - S499
  • [26] Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis
    Yanagimachi, Masakatsu
    Naruto, Takuya
    Hara, Takuma
    Kikuchi, Masako
    Hara, Ryoki
    Miyamae, Takako
    Imagawa, Tomoyuki
    Mori, Masaaki
    Kaneko, Tetsuji
    Morita, Satoshi
    Goto, Hiroaki
    Yokota, Shumpei
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (02) : 237 - 243
  • [27] Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis
    Davis, L. A.
    Polk, B.
    Mann, A.
    Wolff, R. K.
    Kerr, G. S.
    Reimold, A. M.
    Cannon, G. W.
    Mikuls, T. R.
    Caplan, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (03) : 324 - 332
  • [28] GENETIC POLYMORPHISMS IN KEY METHOTREXATE PATHWAY GENES ASSOCIATED WITH RESPONSE TO MTX TREATMENT IN RHEUMATOID ARTHRITIS
    Owen, Sally A.
    Eyre, Stephen
    Martin, Paul
    Hider, Samantha
    Bruce, Ian N.
    Barton, Anne
    Thomson, Wendy
    RHEUMATOLOGY, 2010, 49 : I5 - I5
  • [29] Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
    Owen, S. A.
    Hider, S. L.
    Martin, P.
    Bruce, I. N.
    Barton, A.
    Thomson, W.
    PHARMACOGENOMICS JOURNAL, 2013, 13 (03): : 227 - 234
  • [30] Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients
    S A Owen
    S L Hider
    P Martin
    I N Bruce
    A Barton
    W Thomson
    The Pharmacogenomics Journal, 2013, 13 : 227 - 234